1

Mini-antibodies Revive tumor suppressor p53: The New Pathway for Malignant Therapy

News Discuss 
A critical advance in cancer study is occurring with the use of nanobodies to re-engage damaged p53. This crucial cancer inhibitor protein is frequently disabled in various types of tumors, causing uncontrolled body https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story